These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management of Nocturia and Nocturnal Polyuria. Weiss JP; Everaert K Urology; 2019 Nov; 133S():24-33. PubMed ID: 31586470 [TBL] [Abstract][Full Text] [Related]
6. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study. Wang CJ; Lin YN; Huang SW; Chang CH J Urol; 2011 Jan; 185(1):219-23. PubMed ID: 21074790 [TBL] [Abstract][Full Text] [Related]
7. Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice. Chen SL; Huang YH; Hung TW; Ou YC Int J Clin Pract; 2016 May; 70(5):372-9. PubMed ID: 27039892 [TBL] [Abstract][Full Text] [Related]
8. Desmopressin for treating nocturia in men. Han J; Jung JH; Bakker CJ; Ebell MH; Dahm P Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012059. PubMed ID: 29055129 [TBL] [Abstract][Full Text] [Related]
9. [Management of nocturia: a nosological entity within lower urinary tract symptoms in men]. Peyronnet B; Pradère B; Bruyère F Prog Urol; 2014 Feb; 24(2):80-6. PubMed ID: 24485076 [TBL] [Abstract][Full Text] [Related]
10. Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia. Weiss JP; van Kerrebroeck PE; Klein BM; Nørgaard JP J Urol; 2011 Oct; 186(4):1358-63. PubMed ID: 21855948 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic recommendations for patients with nocturia. Miotła P; Dobruch J; Lipiński M; Drewa T; Kołodziej A; Barcz E; Baranowski W; Rechberger T; Chłosta PL Cent European J Urol; 2017; 70(4):388-393. PubMed ID: 29410891 [TBL] [Abstract][Full Text] [Related]
12. [Advances in clinical study of nocturia]. Guan ZC Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):487-92. PubMed ID: 20721271 [TBL] [Abstract][Full Text] [Related]
14. [Nocturia in men with benign prostatic hyperplasia]. Oelke M; Fangmeyer B; Zinke J; Witt JH Aktuelle Urol; 2018 Aug; 49(4):319-327. PubMed ID: 30086589 [TBL] [Abstract][Full Text] [Related]
15. Current evaluation and treatment of nocturia. Park HK; Kim HG Korean J Urol; 2013 Aug; 54(8):492-8. PubMed ID: 23956822 [TBL] [Abstract][Full Text] [Related]
16. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study. Rovner ES; Raymond K; Andruczyk E; Juul KV Low Urin Tract Symptoms; 2018 Sep; 10(3):221-230. PubMed ID: 28560762 [TBL] [Abstract][Full Text] [Related]
17. Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature. Taha DE; Aboumarzouk OM; Shokeir AA Arab J Urol; 2018 Dec; 16(4):404-410. PubMed ID: 30534439 [TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapeutic options in the treatment of nocturia: an update on the current oral drug therapies. Kim J; Chung E Expert Opin Pharmacother; 2022 Feb; 23(3):405-411. PubMed ID: 34913416 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of nocturia in current clinical practice: who are nocturia patients, and how do we treat them? Drangsholt S; Ruiz MJA; Peyronnet B; Rosenblum N; Nitti V; Brucker B World J Urol; 2019 Jul; 37(7):1389-1394. PubMed ID: 30288596 [TBL] [Abstract][Full Text] [Related]